Trial Profile
A phase I/II, open-label, nonrandomized, dose-finding safety, tolerance, pharmacokinetic, and efficacy study of orally administered S-1 in combination with cisplatin in patients with advanced gastric cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 11 Jun 2014
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 11 Aug 2009 Actual end date (1 May 2006) added as reported by ClinicalTrials.gov
- 11 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 11 Aug 2005 New trial record.